Cyclic AMP and psoriasis — Science News, April 29, 1972
[A team of dermatologists] discovered that cyclic AMP levels in psoriasis lesions are significantly lower than in healthy skin.… [The team] is now trying to find out if the cyclic AMP deficiency causes psoriasis and to develop a medication to increase cyclic AMP levels in psoriasis lesions.
Update
Psoriasis, which affects 2 to 3 percent of the global population, is an inflammatory skin disease marked by red, scaly patches that itch or burn. Low levels of cyclic AMP — a chemical messenger key to cellular communication — haven’t been found to cause the disease. Psoriasis stems from an overactive immune response. Cyclic AMP is just one player alongside other chemical messengers and immune cells, and certain gene variants can make a person more susceptible. The choice among a range of treatment options today depends in part on the severity of the disease and the areas of the body affected. One drug, called apremilast, approved by the U.S. Food and Drug Administration in 2014, increases levels of cyclic AMP, among other actions.
Horned dinosaurs’ weapons evolved to handle the forces of combat 
Artemis II results show how much science people can do at the moon 
Crossword: Time lines 
Many American diets may not include enough of this essential nutrient 
A telling hole in a Neandertal bone hints at a bitter end 
Brain implants are helping people who’ve lost their voice 
WHO scales up Ebola readiness in 22 countries across three continents 
Ukraine: Civilian casualty rates among ‘deadliest’ in years, as energy attacks intensify 
As disasters mount, next UN climate summit faces a test of trust 
Gaza: 340 children killed despite ceasefire agreement – UNICEF